218 related articles for article (PubMed ID: 33140857)
1. CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
Viotto D; Russo F; Anania I; Segatto I; Rampioni Vinciguerra GL; Dall'Acqua A; Bomben R; Perin T; Cusan M; Schiappacassi M; Gerratana L; D'Andrea S; Citron F; Vit F; Musco L; Mattevi MC; Mungo G; Nicoloso MS; Sonego M; Massarut S; Sorio R; Barzan L; Franchin G; Giorda G; Lucia E; Sulfaro S; Giacomarra V; Polesel J; Toffolutti F; Canzonieri V; Puglisi F; Gattei V; Vecchione A; Belletti B; Baldassarre G
J Pathol; 2021 Feb; 253(2):234-245. PubMed ID: 33140857
[TBL] [Abstract][Full Text] [Related]
2. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M
Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511
[TBL] [Abstract][Full Text] [Related]
4. SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.
Hofving T; Elias E; Rehammar A; Inge L; Altiparmak G; Persson M; Kristiansson E; Johansson ME; Nilsson O; Arvidsson Y
BMC Cancer; 2021 Jan; 21(1):101. PubMed ID: 33509126
[TBL] [Abstract][Full Text] [Related]
5. Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors.
Cusan M; Mungo G; De Marco Zompit M; Segatto I; Belletti B; Baldassarre G
Front Endocrinol (Lausanne); 2018; 9():393. PubMed ID: 30065701
[TBL] [Abstract][Full Text] [Related]
6. Loss of p27
Berton S; Cusan M; Segatto I; Citron F; D'Andrea S; Benevol S; Avanzo M; Dall'Acqua A; Schiappacassi M; Bristow RG; Belletti B; Baldassarre G
Sci Rep; 2017 Apr; 7(1):595. PubMed ID: 28377607
[TBL] [Abstract][Full Text] [Related]
7. p27
Bencivenga D; Caldarelli I; Stampone E; Mancini FP; Balestrieri ML; Della Ragione F; Borriello A
Cancer Lett; 2017 Sep; 403():354-365. PubMed ID: 28687353
[TBL] [Abstract][Full Text] [Related]
8. Deletion of Cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environment.
Ding L; Shunkwiler LB; Harper NW; Zhao Y; Hinohara K; Huh SJ; Ekram MB; Guz J; Kern MJ; Awgulewitsch A; Shull JD; Smits BMG; Polyak K
PLoS Genet; 2019 Mar; 15(3):e1008002. PubMed ID: 30893315
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor.
Karpathakis A; Dibra H; Pipinikas C; Feber A; Morris T; Francis J; Oukrif D; Mandair D; Pericleous M; Mohmaduvesh M; Serra S; Ogunbiyi O; Novelli M; Luong T; Asa SL; Kulke M; Toumpanakis C; Meyer T; Caplin M; Meyerson M; Beck S; Thirlwell C
Clin Cancer Res; 2016 Jan; 22(1):250-8. PubMed ID: 26169971
[TBL] [Abstract][Full Text] [Related]
10. A cancer-associated CDKN1B mutation induces p27 phosphorylation on a novel residue: a new mechanism for tumor suppressor loss-of-function.
Bencivenga D; Stampone E; Aulitto A; Tramontano A; Barone C; Negri A; Roberti D; Perrotta S; Della Ragione F; Borriello A
Mol Oncol; 2021 Apr; 15(4):915-941. PubMed ID: 33316141
[TBL] [Abstract][Full Text] [Related]
11. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
[TBL] [Abstract][Full Text] [Related]
12. The genetic landscape of breast carcinomas with neuroendocrine differentiation.
Marchiò C; Geyer FC; Ng CK; Piscuoglio S; De Filippo MR; Cupo M; Schultheis AM; Lim RS; Burke KA; Guerini-Rocco E; Papotti M; Norton L; Sapino A; Weigelt B; Reis-Filho JS
J Pathol; 2017 Feb; 241(3):405-419. PubMed ID: 27925203
[TBL] [Abstract][Full Text] [Related]
13. MEN4 and
Alrezk R; Hannah-Shmouni F; Stratakis CA
Endocr Relat Cancer; 2017 Oct; 24(10):T195-T208. PubMed ID: 28824003
[TBL] [Abstract][Full Text] [Related]
14. Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing's Disease With or Without an MEN4 Phenotype.
Chasseloup F; Pankratz N; Lane J; Faucz FR; Keil MF; Chittiboina P; Kay DM; Hussein Tayeb T; Stratakis CA; Mills JL; Hernández-Ramírez LC
J Clin Endocrinol Metab; 2020 Jun; 105(6):1983-2005. PubMed ID: 32232325
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype.
Occhi G; Regazzo D; Trivellin G; Boaretto F; Ciato D; Bobisse S; Ferasin S; Cetani F; Pardi E; Korbonits M; Pellegata NS; Sidarovich V; Quattrone A; Opocher G; Mantero F; Scaroni C
PLoS Genet; 2013 Mar; 9(3):e1003350. PubMed ID: 23555276
[TBL] [Abstract][Full Text] [Related]
16. NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27
Antony S; Jiang G; Wu Y; Meitzler JL; Makhlouf HR; Haines DC; Butcher D; Hoon DS; Ji J; Zhang Y; Juhasz A; Lu J; Liu H; Dahan I; Konate M; Roy KK; Doroshow JH
Mol Carcinog; 2017 Dec; 56(12):2643-2662. PubMed ID: 28762556
[TBL] [Abstract][Full Text] [Related]
17. Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women.
Ma H; Jin G; Hu Z; Zhai X; Chen W; Wang S; Wang X; Qin J; Gao J; Liu J; Wang X; Wei Q; Shen H
Int J Cancer; 2006 Nov; 119(9):2173-8. PubMed ID: 16804901
[TBL] [Abstract][Full Text] [Related]
18. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
[TBL] [Abstract][Full Text] [Related]
19. Gene delivery of cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitro.
Jiang D; Wang X; Liu X; Li F
Breast Cancer; 2014 Sep; 21(5):614-23. PubMed ID: 23338153
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas.
Costa-Guda J; Marinoni I; Molatore S; Pellegata NS; Arnold A
J Clin Endocrinol Metab; 2011 Apr; 96(4):E701-6. PubMed ID: 21289244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]